Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paperShort communication Published on 2022-10-012022-10-05 Journal: Journal of hepatology [Category] COVID19(2023년), SARS, 바이오마커, 변종, 신약개발, 임상, 진단, 치료제, [키워드] Cancer Care chronic liver disease cirrhosis Community consequence COVID-19 COVID-19 pandemic effective vaccine European Guidance Healthcare professional hepatobiliary cancer Impact liver Liver transplantation Omicron variant Patient patients provide Safe SARS-CoV-2 Treatment vaccination while [DOI] 10.1016/j.jhep.2022.07.008 [Article Type] Short communication
Variable duration of viral shedding in cancer patients with coronavirus disease 2019 (COVID-19)Article Published on 2022-10-012023-07-06 Journal: Infection Control and Hospital Epidemiology [Category] COVID19(2023년), [키워드] Cancer COVID-19 SARS CoV-2 viral shedding [DOI] 10.1017/ice.2021.378 PMC 바로가기
Assessment of anxiety/depression among cancer patients before and during the COVID-19 pandemicArticle Published on 2022-10-012023-07-10 Journal: Psycho-oncology [Category] COVID19(2023년), [키워드] Anxiety Cancer COVID-19 Depression mental health oncology pandemic [DOI] 10.1002/pon.6026 PMC 바로가기
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concernArticle Published on 2022-10-012022-11-15 Journal: ESMO open [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] anti-SARS-CoV-2 Anti-spike antibody BNT162b2 BNT162b2 anti-SARS-CoV-2 vaccine BNT162b2 vaccine booster Cancer cancer patient cell-mediated immune Cellular immune response Concentration COVID-19 delta variant dose evaluated follow-up period highest highlight Hospitalization humoral Immunoglobulin Infection interferon-γ interquartile range longitudinal cohort study lowest median Messenger RNA Neutralizing Neutralizing activity neutralizing antibody of BNT162b2 omicron Oxygen therapy Patient positive response reduced reduction in required SARS-CoV-2 serum Seven solid tumor subject the SARS-CoV-2 third dose Treatment triggering Vaccine variant variants of concern VOCs were measured were used whole blood sample wild-type strain [DOI] 10.1016/j.esmoop.2022.100574 PMC 바로가기
Characterization of coagulopathy and outcomes in cancer patients with severe COVID -19 illness: Longitudinal changes in hospitalized cancer patientsArticle Published on 2022-10-012022-11-15 Journal: Cancer Medicine [Category] COVID19(2023년), SARS, 바이오마커, [키워드] 1:1 Anderson blood cell count Cancer cancer patient Cancer patients CBC center change changes in characterization clinical clinical observations Coagulopathy Complete correlated COVID COVID-19 COVID-19 illness COVID-19 patient Critical CRP death disease elevated feature fibrinogen FIVE future risk had more help hematological hematological cancer Hospital admission Hospital stay Hospitalization Hospitalized IL-6 inflammatory markers interleukin-6 lack longitudinal Lymphocyte count management measure mechanical ventilation mechanism Mortality neutrophil Non-COVID-19 outcome outcomes Peripheral blood Platelet prognostic Prognostic factor required Retrospective analysis risk Risk assessment Serum ferritin severe COVID-19 illness Stratification survival thrombosis Thrombotic complications unique viral infection with COVID-19 [DOI] 10.1002/cam4.4753 PMC 바로가기
Phase separation in immune regulation and immune-related diseasesReview Published on 2022-10-012023-07-10 Journal: Journal of Molecular Medicine (Berlin, Germany) [Category] COVID19(2023년), [키워드] Autoimmunity Cancer Immunity Inflammation phase separation [DOI] 10.1007/s00109-022-02253-9 PMC 바로가기 [Article Type] Review
COVID-19 immunization in people with cancer-Is it safe and efficient? What do we know?Review Published on 2022-10-012023-07-08 Journal: Tumori [Category] COVID19(2023년), [키워드] Antibody Response Breakthrough infection Cancer COVID-19 COVID-19 vaccine immunization malignancy mRNA SARS-CoV-2 [DOI] 10.1177/03008916221090544 [Article Type] Review
Twelve-month observational study of children with cancer in 41 countries during the COVID-19 pandemicObservational Study Published on 2022-10-012023-07-10 Journal: BMJ Global Health [Category] COVID19(2023년), [키워드] Cancer COVID-19 health systems paediatrics [DOI] 10.1136/bmjgh-2022-008797 PMC 바로가기 [Article Type] Observational Study
Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central MassachusettsArticle Published on 2022-10-012022-11-15 Journal: Cancer causes & control : CCC [Category] 바이오마커, [키워드] age Antigen black Breast Breast cancer calculated Cancer Completed COVID-19 COVID-19 pandemic defined diagnoses diagnostic procedure downstream Effect group Health healthcare Hispanic investigated lowest mammography Massachusett Massachusetts monthly rate MRI pandemic Patient performed Prognosis Prostate Prostate cancer Prostate specific antigen Rate reached reflect Screening screening procedure screenings subgroup trend women [DOI] 10.1007/s10552-022-01616-4 PMC 바로가기
Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational studyArticle Published on 2022-10-012022-11-15 Journal: Breast cancer research and treatment [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] Affect Breast Breast cancer breast cancer patient breast cancer patients Cancer cancer treatment CDK4/6 Chemotherapy collected COVID-19 Efficacy enrolled epidermal first vaccination five group growth factor Infection Infection prevention inhibitor inhibitors investigated Japan lowest neutralizing antibody Neutralizing antibody titer Omicron variant pandemic Patient Prevent prospective observational study raising receptor reduction reduction in SARA-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 variant second vaccination Seroconversion seroconversion rate serological response serum sample stratified suggested Support the patient the SARS-CoV-2 therapy Treatment vaccination vaccination efficacy Vaccine variant wild-type [DOI] 10.1007/s10549-022-06693-2 PMC 바로가기